Razma A G, Lynch J P, Wilson B S, Ward P A, Kunkel S L
Am Rev Respir Dis. 1984 Mar;129(3):419-24. doi: 10.1164/arrd.1984.129.3.419.
Alveolar macrophages isolated by bronchoalveolar lavage from nonsmoking patients with sarcoidosis, interstitial pulmonary fibrosis (DIF), and normal volunteers were examined for surface expression of Ia-like (DR) antigen using a monoclonal antibody technique. We found increased percentages of alveolar macrophages expressing DR antigen in the 8 patients with sarcoidosis (77 +/- 3%) and the 7 patients with DIF (78 +/- 3%) over that in the 9 healthy, nonsmoking volunteers (21 +/- 5%, p less than 0.05). Four patients, 2 with DIF and 2 with sarcoidosis, were studied before and 3 months after initiation of therapy. A decrease in DR antigen expression was found to be associated with clinical improvement. Alveolar macrophages from 3 patients were studied serially in culture, with a steady decrease in DR antigen expression with time. We conclude (1) that alveolar macrophages from patients with sarcoidosis and DIF are in a state of heightened activity, and (2) that DR antigen expression may be an indicator of disease activity.
采用单克隆抗体技术,对通过支气管肺泡灌洗从结节病、间质性肺纤维化(DIF)非吸烟患者及正常志愿者中分离出的肺泡巨噬细胞进行Ia样(DR)抗原的表面表达检测。我们发现,8例结节病患者(77±3%)和7例DIF患者(78±3%)中表达DR抗原的肺泡巨噬细胞百分比高于9名健康非吸烟志愿者(21±5%,p<0.05)。对4例患者,2例DIF患者和2例结节病患者,在开始治疗前及治疗3个月后进行了研究。发现DR抗原表达的降低与临床改善相关。对3例患者的肺泡巨噬细胞进行了连续培养研究,随着时间推移DR抗原表达持续下降。我们得出结论:(1)结节病和DIF患者的肺泡巨噬细胞处于活性增强状态;(2)DR抗原表达可能是疾病活动的一个指标。